Janet McGill

22PUBLICATIONS
69CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Epidemiological modellingBehavioural epidemiologyCharacterisation of biological macromoleculesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

|Jun 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|Mar 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Rajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan

|Nov 06, 2025
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.

Amy Mottl, Charlie Scott, Jennifer B Green

|Sep 19, 2025
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.

Hiddo J L Heerspink, Rajiv Agarwal, Antonio J Amor

|Sep 18, 2025
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.

Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink

Pageof 4

Frequent Collaborators

8 joint publications

Peter Rossing

6 joint publications

Rajiv Agarwal

6 joint publications

Hiddo J L Heerspink

5 joint publications

Muthiah Vaduganathan